EQA 2026 - Natriuretic Peptides (CPN) |
---|
Expert Biologists - Program Coordinators:
Delphine COLLIN-CHAVAGNAC, Charlotte CUERQ, Béatrice GUILLEMIN and Bernard POGGI EQA performed since 2008
Number of analytical sites registered in 2025: 655 |
1 - Program Overview
Many natriuretic peptide determination methods are currently available on the market. The external quality assessment of natriuretic peptides helps clinical biologists to assess their own analytical methods but also provides information on the differences in results obtained with the various techniques available.
Depending on the needs revealed by the survey results, additional studies will be performed to improve the understanding and interpretation of the results of this EQA.
The great number of laboratories taking part in the natriuretic peptide program emphasizes the importance of these biomarkers in clinical diagnostics.
2 - Assessment Frequency
Number of surveys per year: 4
Number of control samples per survey: 1 or 2
Number of samples per year: 6
3 - List of Analytes Assessed
4 - Description of the Control Samples
Lyophilized human control plasma and serum (samples to be resuspended in 1 or 2 mL of distilled water).
Our control samples are selected to reproduce patient sample profiles as appropriately as possible.
| Legal notices and privacy policy | General Terms of Sale | | Last updated : 08/09/2025 | Copyright © 2011-2025 ProBioQual All rights reserved. |